Ligand profile
CHEMBL1562069
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_03893 — Succinate-semialdehyde dehydrogenase [NADP+]
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1562069- UniProt (similar protein)
P05091- pchembl
- 6.440 (~363.1 nM)
- Target protein
- KP13_03893
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 43.4
- −1 ≤ LogP ≤ 5 4.11
- MW ≤ 500 Da 256.3
- LogP ≤ 5 4.11
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 43.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCc1cc(=O)oc2cc3oc(C)c(C)c3cc12CCCc1cc(=O)oc2cc3oc(C)c(C)c3cc12
InChI=1S/C16H16O3/c1-4-5-11-6-16(17)19-15-8-14-12(7-13(11)15)9(2)10(3)18-14/h6-8H,4-5H2,1-3H3InChI=1S/C16H16O3/c1-4-5-11-6-16(17)19-15-8-14-12(7-13(11)15)9(2)10(3)18-14/h6-8H,4-5H2,1-3H3
ZPRBNMALSYXIOM-UHFFFAOYSA-NZPRBNMALSYXIOM-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF00171
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1562069 →
- UniProt UniProt P05091 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1562069”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03893.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).